Harald Weber

2.3k total citations · 1 hit paper
26 papers, 1.2k citations indexed

About

Harald Weber is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Harald Weber has authored 26 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Immunology. Recurrent topics in Harald Weber's work include Immunotherapy and Immune Responses (3 papers), Histone Deacetylase Inhibitors Research (3 papers) and Colorectal Cancer Treatments and Studies (2 papers). Harald Weber is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), Histone Deacetylase Inhibitors Research (3 papers) and Colorectal Cancer Treatments and Studies (2 papers). Harald Weber collaborates with scholars based in Germany, United States and Switzerland. Harald Weber's co-authors include Regine Hengge, Volker F. Wendisch, Tino Polen, Johanna Heuveling, Alexandra Possling, Christina Pesavento, Gilbert Tischendorf, Roland Schmid, Dirk W. Höper and Susanne Engelmann and has published in prestigious journals such as Blood, Gastroenterology and Journal of Bacteriology.

In The Last Decade

Harald Weber

22 papers receiving 1.2k citations

Hit Papers

Genome-Wide Analysis of the General Stress Response Netwo... 2005 2026 2012 2019 2005 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harald Weber Germany 9 800 554 195 178 142 26 1.2k
Benjamin M. Alba United States 10 784 1.0× 672 1.2× 314 1.6× 210 1.2× 71 0.5× 14 1.3k
Sabine Hunke Germany 17 624 0.8× 419 0.8× 182 0.9× 133 0.7× 95 0.7× 25 1.2k
Elke Lammertyn Belgium 24 879 1.1× 434 0.8× 267 1.4× 329 1.8× 89 0.6× 48 1.3k
Constantin N. Takacs United States 14 838 1.0× 279 0.5× 75 0.4× 191 1.1× 136 1.0× 18 1.6k
Delphine Patin France 22 896 1.1× 427 0.8× 53 0.3× 149 0.8× 172 1.2× 50 1.4k
B. Duclos France 24 1.3k 1.6× 570 1.0× 110 0.6× 361 2.0× 218 1.5× 42 1.7k
Ho‐Ching Tiffany Tsui United States 25 1.1k 1.4× 767 1.4× 121 0.6× 308 1.7× 233 1.6× 44 2.0k
Maren Scharfe Germany 24 1.3k 1.6× 290 0.5× 128 0.7× 163 0.9× 62 0.4× 34 1.9k
K L Strauch United States 12 712 0.9× 471 0.9× 167 0.9× 136 0.8× 40 0.3× 13 1.1k
Joel F. Schildbach United States 22 995 1.2× 518 0.9× 124 0.6× 251 1.4× 89 0.6× 42 1.4k

Countries citing papers authored by Harald Weber

Since Specialization
Citations

This map shows the geographic impact of Harald Weber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harald Weber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harald Weber more than expected).

Fields of papers citing papers by Harald Weber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harald Weber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harald Weber. The network helps show where Harald Weber may publish in the future.

Co-authorship network of co-authors of Harald Weber

This figure shows the co-authorship network connecting the top 25 collaborators of Harald Weber. A scholar is included among the top collaborators of Harald Weber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harald Weber. Harald Weber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Glasmacher, Axel, Elena Garralda, Chad Gwaltney, et al.. (2025). Dose optimization in cancer drug development: Review and outcome of a multi-stakeholder workshop. European Journal of Cancer. 226. 115593–115593. 1 indexed citations
2.
Weber, Harald, et al.. (2019). Consumers impact on food quality under frozen conditions in Germany. British Food Journal. 122(1). 36–47. 2 indexed citations
3.
Satoh, Taroh, Yung‐Jue Bang, Evgeny Gotovkin, et al.. (2014). Quality of Life in the Trastuzumab for Gastric Cancer Trial. The Oncologist. 19(7). 712–719. 36 indexed citations
4.
Jackisch, Christian, S.-B. Kim, Semiglazov Vf, et al.. (2014). Subcutaneous versus intravenous formulation of trastuzumab for HER2-positive early breast cancer: updated results from the phase III HannaH study. Annals of Oncology. 26(2). 320–325. 86 indexed citations
5.
Hu, Jing, Sofia Paul, Joanne Schindler, et al.. (2009). Characteristics of Thrombocytopenia in Patients Treated with Oral Panobinostat (LBH589).. Blood. 114(22). 2740–2740. 5 indexed citations
6.
Weber, Harald, et al.. (2008). USER SPECIFIC SUPPLY OF DOCUMENTS FOR PRODUCT DEVELOPMENT KNOWLEDGE BY MEANS OF A COMPREHENSIVE TOPIC MAP APPLICATION. 877–884. 1 indexed citations
7.
Weber, Harald, Christina Pesavento, Alexandra Possling, Gilbert Tischendorf, & Regine Hengge. (2006). Cyclic‐di‐GMP‐mediated signalling within the σS network of Escherichia coli. Molecular Microbiology. 62(4). 1014–1034. 207 indexed citations
8.
Weber, Harald. (2006). Providing access to the internet for people with disabilities: Short and medium term research demands. Theoretical Issues in Ergonomics Science. 7(5). 491–498. 9 indexed citations
9.
Weber, Harald, Tino Polen, Johanna Heuveling, Volker F. Wendisch, & Regine Hengge. (2005). Genome-Wide Analysis of the General Stress Response Network in Escherichia coli : σ S -Dependent Genes, Promoters, and Sigma Factor Selectivity. Journal of Bacteriology. 187(5). 1591–1603. 640 indexed citations breakdown →
10.
Weber, Harald, et al.. (2004). Barrierefreiheit im WWW (Web Accessibility). i-com. 3(3). 9–14. 9 indexed citations
12.
Ziebandt, Anne‐Kathrin, Harald Weber, Roland Schmid, et al.. (2001). Extracellular proteins ofStaphylococcus aureus and the role of SarA andσB. PROTEOMICS. 1(4). 480–493. 167 indexed citations
13.
Weber, Harald. (1999). Design for all - a sketch of challenges for HCI designers. International Conference on Human-Computer Interaction. 777–781.
14.
Weber, Harald, et al.. (1999). Symbolic tele-communication using the WWW. International Conference on Human-Computer Interaction. 802–806. 2 indexed citations
15.
Stingl, Georg, E.‐B. Bröcker, Roland Mertelsmann, et al.. (1997). Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene. Journal of Molecular Medicine. 75(4). 297–299. 11 indexed citations
16.
Weber, Harald, G. Zimmermann, & Klaus J. Zink. (1996). Computer Access for People with Special Needs. Computers in Human Services. 12(1-2). 151–168. 2 indexed citations
17.
Stingl, Georg, E.‐B. Bröcker, Roland Mertelsmann, et al.. (1996). Phase I Study to the Immunotherapy of Metastatic Malignant Melanoma by a Cancer Vaccine Consisting of Autologous Cancer Cells Transfected with the Human IL-2 Gene. University of Vienna, Austria. Human Gene Therapy. 7(4). 551–563. 29 indexed citations
18.
Diezel, W, Harald Weber, Jaroslaw P. Maciejewski, & Hans‐Dieter Volk. (1993). The effect of splenopentin (DA SP-5) on In vitro myelopoiesis and on azt-induced bone marrow toxicity. International Journal of Immunopharmacology. 15(3). 269–273. 6 indexed citations
19.
Weber, Harald, et al.. (1990). Splenopentin (DAc-SP-5) accelerates the restoration of myelopoietic and immune systems after sublethal radiation in mice. International Journal of Immunopharmacology. 12(7). 761–768. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026